Viewing Study NCT05069857


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2026-01-23 @ 3:06 PM
Study NCT ID: NCT05069857
Status: RECRUITING
Last Update Posted: 2023-11-22
First Post: 2021-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
Sponsor: Shanghai Jiao Tong University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Oral Squamous Cell Carcinoma View
None Neoadjvant Therapy View
None Anti-PD-1 View
None Anti-VEGFR View
Keywords: